Pembrolizumab monotherapy in patients with primary refractory classical hodgkin lymphoma who relapsed after salvage autologous stem cell transplantation and/or brentuximab vedotin therapy: KEYNOTE-087 subgroup analysis.

ABSTRACT:

SUBMITTER: Zinzani PL 

PROVIDER: S-EPMC7319053 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature